Gastric vs. Transpyloric Feeding for Infants with Severe Bronchopulmonary Dysplasia
This study is looking at the best way to feed infants with severe bronchopulmonary dysplasia (BPD), a serious lung condition, who also have trouble with feeding. It compares two methods: gastric feeding, where a tube goes into the stomach, and transpyloric feeding, where the tube goes past the stomach into the small intestine. The study will enroll about 25 infants, aged 1 month to 1 year, who were born early (before 32 weeks) and are currently in the Le Bonheur NICU with severe BPD and feeding issues. Researchers will measure changes in their breathing (Respiratory Severity Score) after 8 weeks to see which feeding method works better. The current status of this study is unclear.
- Study design
- This is an interventional crossover study, meaning participants will try both feeding methods. About 25 infants will be randomized to start with either gastric or transpyloric feeding.
- What's involved
- Participants will receive 2 weeks of one feeding method, then switch to the other method for 4 weeks. This involves continuous feeding through a tube.
- Compensation
- Not stated in the trial record.
- Follow-up
- Respiratory status will be assessed at 8 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Gastric Feeding Versus Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia, a Crossover Study
At a glance
Conditions
NCT06821776
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Le Bonheur Children's Hospital
Memphis, Tennesseestudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Mark Weems, MD · PRINCIPAL_INVESTIGATOR · University of Tennessee
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Respiratory Severity Score (RSS)8 weeks
RSS (the product of mean airway pressure and oxygen fraction) will be calculated before and after each 2-week intervention block.